Company Name:AVROBIO Inc.
CEO: Geoff Mackay

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Avrobio Inc is a clinical stage gene therapy company. It is engaged in the development of potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose.


Key numbers

Market Capitalization:421501080
Shares Outstanding: 31668000
Float: 22449223.524
Next Earning Date:2020-03-30
TTm EPS: -2.6228
TTm Dividend Rate:
200 days moving average:17.22
50 days moving average: 15.45
One day percent Change: 11.12



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2016-12-31, 2017-12-31, 2018-12-31,
2016-12-31, 2017-12-31, 2018-12-31,